Dustin Plantholt - 24 Sep 2025 Form 4 Insider Report for Health In Tech, Inc. (HIT)

Reporting relationship: Chief AI & Marketing Officer
Issuer ticker: HIT
Reported as of: 24 Sep 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 26 Sep 2025, 19:20:16 UTC
Prior SEC filing: 27 Mar 2025
Source filing: View source filing
Reporting owner signature: /s/ Dustin Plantholt

Key filing fact

Dustin Plantholt filed Form 4 for Health In Tech, Inc. (HIT) on 26 Sep 2025.

Key facts

This page summarizes Dustin Plantholt's Form 4 filing for Health In Tech, Inc. (HIT).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 26 Sep 2025, 19:20.

Change

Previous filing in this sequence was filed on 27 Mar 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002062449 Primary reporting owner

Plantholt Dustin

Relationship: Chief AI & Marketing Officer
Address: 701 S. COLORADO AVE,, SUITE 1, STUART
Signature: /s/ Dustin Plantholt
Signature date: 26 Sep 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

HIT transaction

Class A Common Stock

Award

Transaction value: $0
Shares: +50,000
Change %: +357%
Price: $0.000000
Shares after: 64,000
Date: 24 Sep 2025
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents restricted shares of Class A Common Stock granted to the reporting person pursuant to the Health in Tech Equity Incentive Plan. One third (1/3) of the shares of restricted stock granted to the reporting person shall vest in equal monthly installments over a twelve (12) month period commencing on the date a letter of intent or memorandum of understanding is signed in connection with an initiative being developed by the Company (the "Initiative"), one third (1/3) of the shares shall vest in equal monthly installments over a twelve (12) month period commencing on the date the Initiative enters proof-of-concept or beta launch, and, the remaining one third (1/3) of the shares shall vest in equal monthly installments over a twelve (12) month period commencing on the date of full commercial launch of the Initiative.

Footnote F2

Includes 50,000 shares of restricted stock and 14,000 unrestricted shares of Class A Common Stock.